Furthermore, Schedule III could mean that independent researchers—not just pharma shills—might finally get a seat at the table. Universities won’t have to fear losing their funding just for touching the plant. We might see a new wave of “less biased” research that explores the nuances of the entourage effect or minor cannabinoids like THCV or CBG, rather than just focusing on how much “reefer madness” can be induced in a lab rat.
The years-long push to lock foreign visitors out of the city’s coffeeshops just died in…
When most people think about major hip-hop festivals, Montana rarely enters the conversation. For decades,…
From a black currant sour to an espresso martini riff, here are five THC cocktails…
In the music video for “Ram Pam Pam,” Venezuelan artist Micro TDH put older women…
The new cannabis beverage boom isn’t really about replacing booze. It’s about replacing everything people…
Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity…